Lusian Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 28.75%
- Profit Growth -7.88%
- Ebitda -55.82%
- Net Worth 24.40%
- Total Assets 57.37%
About Lusian Pharmaceuticals
Lusian Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2017 (Seven years and five months 1 days old ). Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Ajay Panwar and Maneesha serve as directors at the Company.
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52609UR2017PTC008067
- Company No.
008067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
What products or services does Lusian Pharmaceuticals Private Limited offer?
Lusian Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Dietary Supplements, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Diclofenac, Multivitamin Syrup & Drops, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Lusian Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Panwar  | Director | 30-Aug-2017 | Current |
| Maneesha | Director | 19-Sep-2017 | Current |
Financial Performance of Lusian Pharmaceuticals.
Lusian Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 28.75% increase. The company also saw a slight decrease in profitability, with a 7.88% decrease in profit. The company's net worth Soared by an impressive increase of 24.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lusian Pharmaceuticals?
In 2018, Lusian Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2018 | Others | ₹1.00 M | Open |
How Many Employees Work at Lusian Pharmaceuticals?
Unlock and access historical data on people associated with Lusian Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lusian Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lusian Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
